2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Dr. Krie and Dr. Yuan discussed treatment-related adverse effects one should be aware of and prepared to manage, recommended management strategies for these TRAEs, and important points to emphasize to patients before they begin treatment.
Welcome to OncLive On Air®! I’m your host today, Caroline Seymour.
OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
In today’s episode, sponsored by Daiichi-Sankyo, we had the pleasure of speaking with Amy Krie, MD, a medical oncologist at Allina Health, and Yuan Yuan, MD, PhD, an associate professor in the Department of Medical Oncology & Therapeutics Research at City of Hope, to discuss the management of adverse effects (AEs) associated with current treatments in breast cancer.
In our exclusive interview, Krie and Yuan discussed treatment-related AEs (TRAEs) one should be aware of and prepared to manage, recommended management strategies for these TRAEs, and important points to emphasize to patients before they begin treatment.